2m 2m 2m 2m 2m 2m 2m
DIAMEDICA THERAP (DMAC)
NASDAQ
$6.52$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $351.6MMarket Cap
- 6.71%1-Year Change
- BiotechnologyIndustry
DIAMEDICA THERAP (DMAC)
$6.52$0.00 (0.00%)
DMAC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.52 | ||
Change | $0.00 (0.00%) | ||
Open | $6.58 | ||
High | $6.73 | ||
Low | $6.50 | ||
Previous Close | $6.52 | ||
Volume | 77,579 | ||
30-Day Average Volume | 150,258 | ||
1-Week Change | -2.40% | ||
1-Month Change | -7.91% | ||
1-Year Change | 6.71% | ||
3-Year Change | 123.29% | ||
5-Year Change | 69.79% | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $45.0M | ||
Market Cap | $351.6M | ||
Enterprise Value | $346.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.1M | ||
Free Cash Flow | -$8.1M | ||
EBIT | -$10.1M | ||
EBITDA | -$10.1M | ||
Net Working Capital | $37.7M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -34 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -34 | ||
PEG | N/A | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue